QQQ   418.91 (-1.06%)
AAPL   165.60 (-0.86%)
MSFT   402.53 (-0.43%)
META   489.57 (-2.44%)
GOOGL   155.31 (-0.45%)
AMZN   176.52 (-1.51%)
TSLA   149.91 (-0.01%)
NVDA   825.35 (-2.52%)
AMD   150.64 (-2.86%)
NIO   3.87 (-3.25%)
BABA   68.81 (-0.10%)
T   16.31 (-0.12%)
F   12.13 (+0.58%)
MU   108.96 (-2.65%)
GE   150.68 (-1.48%)
CGC   7.75 (-1.02%)
DIS   111.76 (-0.60%)
AMC   3.14 (+7.53%)
PFE   25.64 (+0.98%)
PYPL   62.01 (-0.14%)
XOM   120.40 (+1.59%)
QQQ   418.91 (-1.06%)
AAPL   165.60 (-0.86%)
MSFT   402.53 (-0.43%)
META   489.57 (-2.44%)
GOOGL   155.31 (-0.45%)
AMZN   176.52 (-1.51%)
TSLA   149.91 (-0.01%)
NVDA   825.35 (-2.52%)
AMD   150.64 (-2.86%)
NIO   3.87 (-3.25%)
BABA   68.81 (-0.10%)
T   16.31 (-0.12%)
F   12.13 (+0.58%)
MU   108.96 (-2.65%)
GE   150.68 (-1.48%)
CGC   7.75 (-1.02%)
DIS   111.76 (-0.60%)
AMC   3.14 (+7.53%)
PFE   25.64 (+0.98%)
PYPL   62.01 (-0.14%)
XOM   120.40 (+1.59%)
QQQ   418.91 (-1.06%)
AAPL   165.60 (-0.86%)
MSFT   402.53 (-0.43%)
META   489.57 (-2.44%)
GOOGL   155.31 (-0.45%)
AMZN   176.52 (-1.51%)
TSLA   149.91 (-0.01%)
NVDA   825.35 (-2.52%)
AMD   150.64 (-2.86%)
NIO   3.87 (-3.25%)
BABA   68.81 (-0.10%)
T   16.31 (-0.12%)
F   12.13 (+0.58%)
MU   108.96 (-2.65%)
GE   150.68 (-1.48%)
CGC   7.75 (-1.02%)
DIS   111.76 (-0.60%)
AMC   3.14 (+7.53%)
PFE   25.64 (+0.98%)
PYPL   62.01 (-0.14%)
XOM   120.40 (+1.59%)
QQQ   418.91 (-1.06%)
AAPL   165.60 (-0.86%)
MSFT   402.53 (-0.43%)
META   489.57 (-2.44%)
GOOGL   155.31 (-0.45%)
AMZN   176.52 (-1.51%)
TSLA   149.91 (-0.01%)
NVDA   825.35 (-2.52%)
AMD   150.64 (-2.86%)
NIO   3.87 (-3.25%)
BABA   68.81 (-0.10%)
T   16.31 (-0.12%)
F   12.13 (+0.58%)
MU   108.96 (-2.65%)
GE   150.68 (-1.48%)
CGC   7.75 (-1.02%)
DIS   111.76 (-0.60%)
AMC   3.14 (+7.53%)
PFE   25.64 (+0.98%)
PYPL   62.01 (-0.14%)
XOM   120.40 (+1.59%)
NASDAQ:BMTI

(BMTI) (BMTI) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
BMTI stock logo

About (BMTI) Stock (NASDAQ:BMTI)

BioMimetic Therapeutics, Inc. is a biotechnology company engaged in developing and commercializing products to the healing of musculoskeletal injuries and diseases, including therapies for orthopedic, sports medicine and spine applications. The Company’s Augment platform of product and product candidates include an engineered version of recombinant human platelet-derived growth factor BB (rhPDGF-BB), one of the wound healing and tissue repair stimulators in the body. Its platform regenerative technology for promoting tissue healing and regeneration combines rhPDGF-BB with tissue specific matrices, when appropriate. The matrices are engineered or natural scaffold materials, such as Beta Tri-Calcium Phosphate. The Company’s product candidates include Augment Bone Graft (Augment), Augmen Injectable Bone Graft (Augment Injectable) and Augment Rotator Cuff Graft (Augment Rotator Cuff Graft). In March 2013, Wright Medical Group Inc completed acquisition of BioMimetic Therapeutics, Inc.

BMTI Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com
Receive BMTI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for (BMTI) and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
N/A
Industry
N/A
Sub-Industry
N/A
Current Symbol
NASDAQ:BMTI
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report

This page (NASDAQ:BMTI) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners